The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
Clearing 19 biologics for Europe market
Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
CEO Stéphane Bancel framed the changes as essential to scaling the business
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
